Scholarly Article
Sleep Quality in Hemodialysis Patients According to Renal Anemia Treatment Outcomes
Basaran, Elif, Cihan Uysal
2025-12-17 · Advances in Modern Biomedicine · Cultech Publishing Sdn. Bhd.
Abstract
Backgound: We assessed the impact of renal anemia treatment on sleep quality among hemodialysis (HD) patients. Methods: To be included in the study, patients had to have received epoetin (EPO) therapy within the past year. Sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI), with poor sleepers defined as those with a global PSQI score > 5. The target hemoglobin level (THb) was defined as a hemoglobin (Hb) level greater than 11.0 g/dL in the three months preceding the sleep survey. Results: A total of 78 patients were included, with a median age of 59.0 years. The mean HD vintage was 50.5 months. THb levels were achieved in 43 patients (55.1%), while 46 patients (59.0%) were identified as poor sleepers. Median PSQI score was 6 (4-11) in patients who achieved THb, compared with 7 (4-9) in those who did not (p=0.217). Mean Hb level was 11.2±1.3 g/dL among poor sleepers and 11.3±1.2 g/dL among non-poor sleepers (p=0.603). There was no significant correlation between PSQI score and Hb level (p=0.955). The frequency of poor sleepers was significantly higher in patients receiving EPO therapy (68.0%) compared to those not receiving EPO therapy (42.8%) (p=0.027). Furthermore, EPO use was identified as an independent risk factor for poor sleep quality (OR: 2.822, 95% CI: 1.029-7.737). Neither Hb level nor achieving THb were found to be independent predictors of poor sleep quality. Conclusion: Successful anemia treatment did not have a positive impact on sleep quality among HD patients.
Keywords
Hemodialysis, Anemia, Epoetin, Erythropoietin, Sleep quality
Citation Details
Advances in Modern Biomedicine, pp. 1-10